2023 Q2 Form 10-Q Financial Statement

#000095017023015263 Filed on April 27, 2023

View on sec.gov

Income Statement

Concept 2023 Q2 2023 Q1 2022 Q1
Revenue $138.2M $138.7M $134.3M
YoY Change -1.79% 3.25% 4.82%
Cost Of Revenue $42.76M $43.22M $42.12M
YoY Change -0.34% 2.61% 5.56%
Gross Profit $95.40M $95.47M $92.20M
YoY Change -2.43% 3.55% 4.42%
Gross Profit Margin 69.05% 68.84% 68.64%
Selling, General & Admin $14.03M $10.65M $12.25M
YoY Change 23.59% -13.11% -29.59%
% of Gross Profit 14.71% 11.15% 13.29%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $58.70M $54.02M $50.36M
YoY Change 15.05% 7.25% 10.45%
% of Gross Profit 61.53% 56.58% 54.62%
Operating Expenses $72.73M $107.9M $62.62M
YoY Change -32.54% 72.29% -43.13%
Operating Profit $22.67M -$12.41M $29.59M
YoY Change -326.02% -141.94% -235.68%
Interest Expense -$16.30M $19.92M $18.26M
YoY Change -186.22% 9.12% -5.86%
% of Operating Profit -71.9% 61.71%
Other Income/Expense, Net -$634.0K -$20.61M -$504.0K
YoY Change -96.84% 3989.29% 37.7%
Pretax Income $5.715M $15.52M $14.21M
YoY Change -90.59% 9.21% -14.14%
Income Tax $362.0K $213.0K $252.0K
% Of Pretax Income 6.33% 1.37% 1.77%
Net Earnings $2.476M $15.28M $13.94M
YoY Change -95.9% 9.66% -12.94%
Net Earnings / Revenue 1.79% 11.02% 10.38%
Basic Earnings Per Share $0.01 $0.06 $0.05
Diluted Earnings Per Share $0.01 $0.06 $0.05
COMMON SHARES
Basic Shares Outstanding 209.3M 210.4M 212.1M
Diluted Shares Outstanding 209.4M 210.4M 213.2M

Balance Sheet

Concept 2023 Q2 2023 Q1 2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $28.04M $25.03M $17.19M
YoY Change -27.23% 45.65% -91.0%
Cash & Equivalents $28.04M $25.03M $17.19M
Short-Term Investments
Other Short-Term Assets $10.23M $19.28M $13.96M
YoY Change 16.84% 38.12% -0.29%
Inventory
Prepaid Expenses
Receivables $61.38M $59.86M $52.48M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $99.65M $104.2M $83.63M
YoY Change -2.42% 24.57% -68.91%
LONG-TERM ASSETS
Property, Plant & Equipment $3.819B $3.800B $3.798B
YoY Change -2.75% 0.06% 7.26%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $40.56M $45.58M $57.05M
YoY Change -23.52% -20.11% -78.55%
Other Assets $6.977M $7.401M $5.675M
YoY Change -38.0% 30.41% -36.94%
Total Long-Term Assets $3.961B $3.949B $3.968B
YoY Change -3.41% -0.47% 1.58%
TOTAL ASSETS
Total Short-Term Assets $99.65M $104.2M $83.63M
Total Long-Term Assets $3.961B $3.949B $3.968B
Total Assets $4.061B $4.053B $4.051B
YoY Change -3.39% 0.04% -2.96%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $210.9M $195.8M $206.3M
YoY Change -1.96% -5.1% 5.82%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $241.0M $225.9M $237.0M
YoY Change -1.96% -4.69% 6.29%
LONG-TERM LIABILITIES
Long-Term Debt $1.795B $1.782B $1.758B
YoY Change -3.84% 1.36% -1.22%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $1.795B $1.782B $1.758B
YoY Change -3.84% 1.36% -1.22%
TOTAL LIABILITIES
Total Short-Term Liabilities $241.0M $225.9M $237.0M
Total Long-Term Liabilities $1.795B $1.782B $1.758B
Total Liabilities $2.036B $2.008B $1.995B
YoY Change -3.62% 0.64% -0.58%
SHAREHOLDERS EQUITY
Retained Earnings
YoY Change
Common Stock $21.44M $21.44M $21.42M
YoY Change 0.0% 0.09%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $2.025B $2.039B $2.050B
YoY Change
Total Liabilities & Shareholders Equity $4.061B $4.053B $4.051B
YoY Change -3.39% 0.04% -2.96%

Cashflow Statement

Concept 2023 Q2 2023 Q1 2022 Q1
OPERATING ACTIVITIES
Net Income $2.476M $15.28M $13.94M
YoY Change -95.9% 9.66% -12.94%
Depreciation, Depletion And Amortization $58.70M $54.02M $50.36M
YoY Change 15.05% 7.25% 10.45%
Cash From Operating Activities $84.63M $42.17M $50.02M
YoY Change 3.1% -15.7% -10.85%
INVESTING ACTIVITIES
Capital Expenditures $71.57M $54.49M -$158.2M
YoY Change -136.35% -134.45% 773.97%
Acquisitions
YoY Change
Other Investing Activities $9.438M $3.667M $3.684M
YoY Change -84.88% -0.46% -87.16%
Cash From Investing Activities -$62.13M -$50.83M -$154.5M
YoY Change -53.79% -67.1% -1566.02%
FINANCING ACTIVITIES
Cash Dividend Paid $30.35M $28.21M
YoY Change 7.6% 90.03%
Common Stock Issuance & Retirement, Net $33.78M
YoY Change -114.98%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -19.37M 12.90M 80.45M
YoY Change -126.06% -83.96% 52.82%
NET CHANGE
Cash From Operating Activities 84.63M 42.17M 50.02M
Cash From Investing Activities -62.13M -50.83M -154.5M
Cash From Financing Activities -19.37M 12.90M 80.45M
Net Change In Cash 3.134M 4.245M -24.04M
YoY Change -85.73% -117.66% -120.15%
FREE CASH FLOW
Cash From Operating Activities $84.63M $42.17M $50.02M
Capital Expenditures $71.57M $54.49M -$158.2M
Free Cash Flow $13.06M -$12.33M $208.2M
YoY Change -95.32% -105.92% 180.57%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q1 us-gaap Development In Process
DevelopmentInProcess
57276000
CY2022Q4 us-gaap Development In Process
DevelopmentInProcess
56466000
CY2023Q1 us-gaap Real Estate Investment Property Net
RealEstateInvestmentPropertyNet
3782242000
CY2022Q4 us-gaap Real Estate Investment Property Net
RealEstateInvestmentPropertyNet
3780260000
CY2023Q1 sitc Investments In And Advances To Joint Ventures
InvestmentsInAndAdvancesToJointVentures
45577000
CY2022Q4 sitc Investments In And Advances To Joint Ventures
InvestmentsInAndAdvancesToJointVentures
44608000
CY2023Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
25034000
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
20254000
CY2023Q1 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
425000
CY2022Q4 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
960000
CY2023Q1 us-gaap Accounts Receivable Net
AccountsReceivableNet
59857000
CY2022Q4 us-gaap Accounts Receivable Net
AccountsReceivableNet
63926000
CY2023Q1 us-gaap Other Assets
OtherAssets
140050000
CY2022Q4 us-gaap Other Assets
OtherAssets
135009000
CY2023Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
4053185000
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
4045017000
CY2023Q1 us-gaap Senior Notes
SeniorNotes
1454462000
CY2022Q4 us-gaap Senior Notes
SeniorNotes
1453923000
CY2023Q1 sitc Unsecured Term Loan
UnsecuredTermLoan
198605000
CY2022Q4 sitc Unsecured Term Loan
UnsecuredTermLoan
198521000
CY2023Q1 us-gaap Line Of Credit
LineOfCredit
75000000
CY2022Q4 us-gaap Line Of Credit
LineOfCredit
0
CY2023Q1 sitc Unsecured Indebtedness
UnsecuredIndebtedness
1728067000
CY2023Q1 us-gaap Real Estate Investment Property Accumulated Depreciation
RealEstateInvestmentPropertyAccumulatedDepreciation
1696184000
CY2022Q4 us-gaap Real Estate Investment Property Accumulated Depreciation
RealEstateInvestmentPropertyAccumulatedDepreciation
1652899000
CY2023Q1 sitc Real Estate Assets Net Before Construction In Progress And Land
RealEstateAssetsNetBeforeConstructionInProgressAndLand
3724966000
CY2022Q4 sitc Real Estate Assets Net Before Construction In Progress And Land
RealEstateAssetsNetBeforeConstructionInProgressAndLand
3723794000
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2023Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2023Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2023Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2023Q1 dei Amendment Flag
AmendmentFlag
false
CY2023Q1 dei Entity Central Index Key
EntityCentralIndexKey
0000894315
CY2023Q1 dei Document Type
DocumentType
10-Q
CY2023Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2023Q1 dei Document Period End Date
DocumentPeriodEndDate
2023-03-31
CY2023Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2023Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2023Q1 dei Entity File Number
EntityFileNumber
1-11690
CY2023Q1 dei Entity Registrant Name
EntityRegistrantName
SITE Centers Corp.
CY2023Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
OH
CY2023Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
34-1723097
CY2023Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
3300 Enterprise Parkway
CY2023Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
Beachwood
CY2023Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
OH
CY2023Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
44122
CY2023Q1 dei City Area Code
CityAreaCode
216
CY2023Q1 dei Local Phone Number
LocalPhoneNumber
755-5500
CY2023Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.10
CY2023Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023Q1 dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2023Q1 dei Entity Small Business
EntitySmallBusiness
false
CY2023Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2023Q1 dei Entity Shell Company
EntityShellCompany
false
CY2023Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
209258120
CY2023Q1 us-gaap Land
Land
1073726000
CY2022Q4 us-gaap Land
Land
1066852000
CY2023Q1 us-gaap Investment Building And Building Improvements
InvestmentBuildingAndBuildingImprovements
3755415000
CY2022Q4 us-gaap Investment Building And Building Improvements
InvestmentBuildingAndBuildingImprovements
3733805000
CY2023Q1 us-gaap Fixtures And Equipment Gross
FixturesAndEquipmentGross
592009000
CY2022Q4 us-gaap Fixtures And Equipment Gross
FixturesAndEquipmentGross
576036000
CY2023Q1 sitc Real Estate Assets At Cost Before Construction In Progress And Land
RealEstateAssetsAtCostBeforeConstructionInProgressAndLand
5421150000
CY2022Q4 sitc Real Estate Assets At Cost Before Construction In Progress And Land
RealEstateAssetsAtCostBeforeConstructionInProgressAndLand
5376693000
CY2022Q4 sitc Unsecured Indebtedness
UnsecuredIndebtedness
1652444000
CY2023Q1 us-gaap Notes And Loans Payable
NotesAndLoansPayable
54201000
CY2022Q4 us-gaap Notes And Loans Payable
NotesAndLoansPayable
54577000
CY2023Q1 us-gaap Debt Longterm And Shortterm Combined Amount
DebtLongtermAndShorttermCombinedAmount
1782268000
CY2022Q4 us-gaap Debt Longterm And Shortterm Combined Amount
DebtLongtermAndShorttermCombinedAmount
1707021000
CY2023Q1 us-gaap Accounts Payable And Accrued Liabilities Current And Noncurrent
AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent
195825000
CY2022Q4 us-gaap Accounts Payable And Accrued Liabilities Current And Noncurrent
AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent
214985000
CY2023Q1 us-gaap Dividends Payable Current And Noncurrent
DividendsPayableCurrentAndNoncurrent
30081000
CY2022Q4 us-gaap Dividends Payable Current And Noncurrent
DividendsPayableCurrentAndNoncurrent
30389000
CY2023Q1 us-gaap Liabilities
Liabilities
2008174000
CY2022Q4 us-gaap Liabilities
Liabilities
1952395000
CY2023Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.10
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.10
CY2023Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
300000000
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
300000000
CY2023Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
214372008
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
214371498
CY2023Q1 us-gaap Common Stock Value
CommonStockValue
21437000
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
21437000
CY2023Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
5966089000
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
5974216000
CY2023Q1 us-gaap Accumulated Distributions In Excess Of Net Income
AccumulatedDistributionsInExcessOfNetIncome
4061167000
CY2022Q4 us-gaap Accumulated Distributions In Excess Of Net Income
AccumulatedDistributionsInExcessOfNetIncome
4046370000
CY2023Q1 us-gaap Deferred Compensation Liability Current And Noncurrent
DeferredCompensationLiabilityCurrentAndNoncurrent
5055000
CY2022Q4 us-gaap Deferred Compensation Liability Current And Noncurrent
DeferredCompensationLiabilityCurrentAndNoncurrent
5025000
CY2023Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
5838000
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
9038000
CY2023Q1 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
5386964
CY2022Q4 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
3787279
CY2023Q1 us-gaap Treasury Stock Common Value
TreasuryStockCommonValue
73035000
CY2022Q4 us-gaap Treasury Stock Common Value
TreasuryStockCommonValue
51518000
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
2039217000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
2086828000
CY2023Q1 us-gaap Minority Interest
MinorityInterest
5794000
CY2022Q4 us-gaap Minority Interest
MinorityInterest
5794000
CY2023Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
2045011000
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
2092622000
CY2023Q1 us-gaap Assets
Assets
4053185000
CY2022Q4 us-gaap Assets
Assets
4045017000
CY2023Q1 sitc Rental Income
RentalIncome
135872000
CY2022Q1 sitc Rental Income
RentalIncome
129884000
CY2023Q1 sitc Fee And Other Income Including Revenue From Contracts With Customers
FeeAndOtherIncomeIncludingRevenueFromContractsWithCustomers
2820000
CY2022Q1 sitc Fee And Other Income Including Revenue From Contracts With Customers
FeeAndOtherIncomeIncludingRevenueFromContractsWithCustomers
4436000
CY2023Q1 us-gaap Revenues
Revenues
138692000
CY2022Q1 us-gaap Revenues
Revenues
134320000
CY2023Q1 us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
23166000
CY2022Q1 us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
21936000
CY2023Q1 us-gaap Real Estate Tax Expense
RealEstateTaxExpense
20053000
CY2022Q1 us-gaap Real Estate Tax Expense
RealEstateTaxExpense
20183000
CY2023Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
10645000
CY2022Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
12251000
CY2023Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
54016000
CY2022Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
50364000
CY2023Q1 us-gaap Operating Expenses
OperatingExpenses
107880000
CY2022Q1 us-gaap Operating Expenses
OperatingExpenses
104734000
CY2023Q1 us-gaap Interest Expense
InterestExpense
19923000
CY2022Q1 us-gaap Interest Expense
InterestExpense
18258000
CY2023Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-687000
CY2022Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-504000
CY2023Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-20610000
CY2022Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-18762000
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
10202000
CY2022Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
10824000
CY2023Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
1359000
CY2022Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
169000
CY2023Q1 us-gaap Business Combination Step Acquisition Equity Interest In Acquiree Remeasurement Gain Or Loss
BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGainOrLoss
3749000
CY2022Q1 us-gaap Business Combination Step Acquisition Equity Interest In Acquiree Remeasurement Gain Or Loss
BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGainOrLoss
3356000
CY2023Q1 us-gaap Gain Loss On Sale Of Properties
GainLossOnSaleOfProperties
205000
CY2022Q1 us-gaap Gain Loss On Sale Of Properties
GainLossOnSaleOfProperties
-142000
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
15515000
CY2022Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
14207000
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
213000
CY2022Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
252000
CY2023Q1 us-gaap Profit Loss
ProfitLoss
15302000
CY2022Q1 us-gaap Profit Loss
ProfitLoss
13955000
CY2023Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
18000
CY2022Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
18000
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
15284000
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
13937000
CY2023Q1 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
2789000
CY2022Q1 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
2789000
CY2023Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
12495000
CY2022Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
11148000
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.06
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.05
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.06
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.05
CY2023Q1 us-gaap Profit Loss
ProfitLoss
15302000
CY2022Q1 us-gaap Profit Loss
ProfitLoss
13955000
CY2023Q1 us-gaap Increase Decrease In Fair Value Of Interest Rate Fair Value Hedging Instruments1
IncreaseDecreaseInFairValueOfInterestRateFairValueHedgingInstruments1
-3200000
CY2022Q1 us-gaap Increase Decrease In Fair Value Of Interest Rate Fair Value Hedging Instruments1
IncreaseDecreaseInFairValueOfInterestRateFairValueHedgingInstruments1
0
CY2023Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-3200000
CY2022Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
0
CY2023Q1 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
12102000
CY2022Q1 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
13955000
CY2023Q1 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
18000
CY2022Q1 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
18000
CY2023Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
12084000
CY2022Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
13937000
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
2092622000
CY2023Q1 sitc Stock Issued During Period Value Share Based Compensation Net Of Costs
StockIssuedDuringPeriodValueShareBasedCompensationNetOfCosts
6000
CY2023Q1 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
26611000
CY2023Q1 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
-3009000
CY2023Q1 us-gaap Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
18000
CY2023Q1 us-gaap Dividends Common Stock
DividendsCommonStock
27292000
CY2023Q1 us-gaap Dividends Preferred Stock
DividendsPreferredStock
2789000
CY2023Q1 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
12102000
CY2023Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
2045011000
CY2021Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
2042652000
CY2022Q1 sitc Stock Issued During Period Value Share Based Compensation Net Of Costs
StockIssuedDuringPeriodValueShareBasedCompensationNetOfCosts
69000
CY2022Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
33781000
CY2022Q1 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
-3627000
CY2022Q1 us-gaap Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
18000
CY2022Q1 us-gaap Dividends Common Stock
DividendsCommonStock
27905000
CY2022Q1 us-gaap Dividends Preferred Stock
DividendsPreferredStock
2789000
CY2022Q1 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
13955000
CY2022Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
2056118000
CY2023Q1 us-gaap Profit Loss
ProfitLoss
15302000
CY2022Q1 us-gaap Profit Loss
ProfitLoss
13955000
CY2023Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
54016000
CY2022Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
50364000
CY2023Q1 us-gaap Share Based Compensation
ShareBasedCompensation
1760000
CY2022Q1 us-gaap Share Based Compensation
ShareBasedCompensation
1823000
CY2023Q1 sitc Amortization And Write Off Of Debt Issuance Costs And Fair Market Value Of Debt Adjustments
AmortizationAndWriteOffOfDebtIssuanceCostsAndFairMarketValueOfDebtAdjustments
1111000
CY2022Q1 sitc Amortization And Write Off Of Debt Issuance Costs And Fair Market Value Of Debt Adjustments
AmortizationAndWriteOffOfDebtIssuanceCostsAndFairMarketValueOfDebtAdjustments
1145000
CY2023Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
1359000
CY2022Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
169000
CY2023Q1 us-gaap Equity Method Investment Dividends Or Distributions
EquityMethodInvestmentDividendsOrDistributions
0
CY2022Q1 us-gaap Equity Method Investment Dividends Or Distributions
EquityMethodInvestmentDividendsOrDistributions
883000
CY2023Q1 us-gaap Business Combination Step Acquisition Equity Interest In Acquiree Remeasurement Gain Or Loss
BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGainOrLoss
3749000
CY2022Q1 us-gaap Business Combination Step Acquisition Equity Interest In Acquiree Remeasurement Gain Or Loss
BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGainOrLoss
3356000
CY2023Q1 us-gaap Gain Loss On Sale Of Properties
GainLossOnSaleOfProperties
205000
CY2022Q1 us-gaap Gain Loss On Sale Of Properties
GainLossOnSaleOfProperties
-142000
CY2023Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-4819000
CY2022Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-6815000
CY2023Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-16205000
CY2022Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-14257000
CY2023Q1 us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
13323000
CY2022Q1 us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
7324000
CY2023Q1 us-gaap Adjustments To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities
AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities
26865000
CY2022Q1 us-gaap Adjustments To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities
AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities
36066000
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
42167000
CY2022Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
50021000
CY2023Q1 us-gaap Payments To Acquire Real Estate
PaymentsToAcquireRealEstate
26503000
CY2022Q1 us-gaap Payments To Acquire Real Estate
PaymentsToAcquireRealEstate
133463000
CY2023Q1 us-gaap Payments To Develop Real Estate Assets
PaymentsToDevelopRealEstateAssets
27990000
CY2022Q1 us-gaap Payments To Develop Real Estate Assets
PaymentsToDevelopRealEstateAssets
24725000
CY2023Q1 sitc Proceeds From Disposition Of Joint Venture Interests
ProceedsFromDispositionOfJointVentureInterests
3405000
CY2022Q1 sitc Proceeds From Disposition Of Joint Venture Interests
ProceedsFromDispositionOfJointVentureInterests
0
CY2023Q1 us-gaap Proceeds From Real Estate And Real Estate Joint Ventures
ProceedsFromRealEstateAndRealEstateJointVentures
0
CY2022Q1 us-gaap Proceeds From Real Estate And Real Estate Joint Ventures
ProceedsFromRealEstateAndRealEstateJointVentures
156000
CY2023Q1 us-gaap Payments To Acquire Interest In Joint Venture
PaymentsToAcquireInterestInJointVenture
56000
CY2022Q1 us-gaap Payments To Acquire Interest In Joint Venture
PaymentsToAcquireInterestInJointVenture
55000
CY2023Q1 sitc Repayments Of Joint Venture Advances Net
RepaymentsOfJointVentureAdvancesNet
-318000
CY2022Q1 sitc Repayments Of Joint Venture Advances Net
RepaymentsOfJointVentureAdvancesNet
0
CY2023Q1 us-gaap Proceeds From Equity Method Investment Dividends Or Distributions Return Of Capital
ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital
0
CY2022Q1 us-gaap Proceeds From Equity Method Investment Dividends Or Distributions Return Of Capital
ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital
3583000
CY2023Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-50826000
CY2022Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-154504000
CY2023Q1 us-gaap Proceeds From Repayments Of Lines Of Credit
ProceedsFromRepaymentsOfLinesOfCredit
75000000
CY2022Q1 us-gaap Proceeds From Repayments Of Lines Of Credit
ProceedsFromRepaymentsOfLinesOfCredit
115000000
CY2023Q1 us-gaap Repayments Of First Mortgage Bond
RepaymentsOfFirstMortgageBond
314000
CY2022Q1 us-gaap Repayments Of First Mortgage Bond
RepaymentsOfFirstMortgageBond
34696000
CY2023Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
0
CY2022Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
33781000
CY2023Q1 sitc Proceeds From Repurchase Of Common Shares
ProceedsFromRepurchaseOfCommonShares
-4800000
CY2022Q1 sitc Proceeds From Repurchase Of Common Shares
ProceedsFromRepurchaseOfCommonShares
-5415000
CY2023Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
26611000
CY2022Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
0
CY2023Q1 us-gaap Payments To Minority Shareholders
PaymentsToMinorityShareholders
18000
CY2022Q1 us-gaap Payments To Minority Shareholders
PaymentsToMinorityShareholders
17000
CY2023Q1 us-gaap Payments Of Dividends
PaymentsOfDividends
30353000
CY2022Q1 us-gaap Payments Of Dividends
PaymentsOfDividends
28208000
CY2023Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
12904000
CY2022Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
80445000
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
4245000
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-24038000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
21214000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
43252000
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
25459000
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
19214000
CY2023Q1 us-gaap Other Assets Miscellaneous
OtherAssetsMiscellaneous
3704000
CY2023Q1 us-gaap Use Of Estimates
UseOfEstimates
<p style="text-indent:2.267%;font-size:10.0pt;margin-top:10.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Use of Estimates in Preparation of Financial Statements</span></p><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The preparation of financial statements in conformity with generally accepted accounting principles (“GAAP”) requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities and the reported amounts of revenues and expenses during the year. Actual results could differ from those estimates. </span>
CY2022Q4 us-gaap Other Assets Miscellaneous
OtherAssetsMiscellaneous
3491000
CY2023Q1 us-gaap Deposits Assets
DepositsAssets
3239000
CY2022Q4 us-gaap Deposits Assets
DepositsAssets
3188000
CY2023Q1 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
6976000
CY2022Q4 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
7526000
CY2023Q1 us-gaap Other Assets
OtherAssets
140050000
CY2022Q4 us-gaap Other Assets
OtherAssets
135009000
CY2023Q1 us-gaap Below Market Lease Net
BelowMarketLeaseNet
58734000
CY2023Q1 sitc Consolidation Of The Net Assets Of Unconsolidated Joint Ventures Excluding Mortgages
ConsolidationOfTheNetAssetsOfUnconsolidatedJointVenturesExcludingMortgages
0
CY2022Q1 sitc Consolidation Of The Net Assets Of Unconsolidated Joint Ventures Excluding Mortgages
ConsolidationOfTheNetAssetsOfUnconsolidatedJointVenturesExcludingMortgages
42800000
CY2023Q1 sitc Net Assets Acquired From An Unconsolidated Joint Venture
NetAssetsAcquiredFromAnUnconsolidatedJointVenture
0
CY2022Q1 sitc Net Assets Acquired From An Unconsolidated Joint Venture
NetAssetsAcquiredFromAnUnconsolidatedJointVenture
8500000
CY2023Q1 us-gaap Dividends Payable Current And Noncurrent
DividendsPayableCurrentAndNoncurrent
30100000
CY2022Q1 us-gaap Dividends Payable Current And Noncurrent
DividendsPayableCurrentAndNoncurrent
30700000
CY2023Q1 us-gaap Construction In Progress Expenditures Incurred But Not Yet Paid
ConstructionInProgressExpendituresIncurredButNotYetPaid
10300000
CY2022Q1 us-gaap Construction In Progress Expenditures Incurred But Not Yet Paid
ConstructionInProgressExpendituresIncurredButNotYetPaid
10500000
CY2023Q1 sitc Company Share In Accumulated Equity Of Unconsolidated Joint Ventures
CompanyShareInAccumulatedEquityOfUnconsolidatedJointVentures
43437000
CY2022Q4 sitc Company Share In Accumulated Equity Of Unconsolidated Joint Ventures
CompanyShareInAccumulatedEquityOfUnconsolidatedJointVentures
42644000
CY2023Q1 us-gaap Equity Method Investment Difference Between Carrying Amount And Underlying Equity
EquityMethodInvestmentDifferenceBetweenCarryingAmountAndUnderlyingEquity
-442000
CY2022Q4 us-gaap Equity Method Investment Difference Between Carrying Amount And Underlying Equity
EquityMethodInvestmentDifferenceBetweenCarryingAmountAndUnderlyingEquity
-707000
CY2023Q1 sitc Equity Method Investment Difference Between Carrying Amount And Underlying Equity Deferred Development Fees Net Of Portion Relating To Company Interest
EquityMethodInvestmentDifferenceBetweenCarryingAmountAndUnderlyingEquityDeferredDevelopmentFeesNetOfPortionRelatingToCompanyInterest
245000
CY2022Q4 sitc Equity Method Investment Difference Between Carrying Amount And Underlying Equity Deferred Development Fees Net Of Portion Relating To Company Interest
EquityMethodInvestmentDifferenceBetweenCarryingAmountAndUnderlyingEquityDeferredDevelopmentFeesNetOfPortionRelatingToCompanyInterest
301000
CY2023Q1 us-gaap Due From Joint Ventures
DueFromJointVentures
2827000
CY2022Q4 us-gaap Due From Joint Ventures
DueFromJointVentures
2972000
CY2023Q1 us-gaap Investments In Affiliates Subsidiaries Associates And Joint Ventures
InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
45577000
CY2022Q4 us-gaap Investments In Affiliates Subsidiaries Associates And Joint Ventures
InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
44608000
CY2023Q1 sitc Income Loss From Equity Method Investments Before Amortization Of Basis Differentials
IncomeLossFromEquityMethodInvestmentsBeforeAmortizationOfBasisDifferentials
950000
CY2022Q1 sitc Income Loss From Equity Method Investments Before Amortization Of Basis Differentials
IncomeLossFromEquityMethodInvestmentsBeforeAmortizationOfBasisDifferentials
30000
CY2023Q1 sitc Amortization Of Basis Differentials
AmortizationOfBasisDifferentials
409000
CY2022Q1 sitc Amortization Of Basis Differentials
AmortizationOfBasisDifferentials
139000
CY2023Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
1359000
CY2022Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
169000
CY2022Q4 us-gaap Below Market Lease Net
BelowMarketLeaseNet
59825000
CY2023Q1 sitc Amortization Of Intangible Assets Excluding Above And Below Market Leases
AmortizationOfIntangibleAssetsExcludingAboveAndBelowMarketLeases
6200000
CY2022Q1 sitc Amortization Of Intangible Assets Excluding Above And Below Market Leases
AmortizationOfIntangibleAssetsExcludingAboveAndBelowMarketLeases
6600000
CY2023Q1 sitc Other Revenue Earned From Unconsolidated Joint Ventures
OtherRevenueEarnedFromUnconsolidatedJointVentures
200000
CY2022Q1 sitc Other Revenue Earned From Unconsolidated Joint Ventures
OtherRevenueEarnedFromUnconsolidatedJointVentures
400000
CY2023Q1 sitc Fee And Other Income Earned From Unconsolidated Joint Ventures
FeeAndOtherIncomeEarnedFromUnconsolidatedJointVentures
1800000
CY2022Q1 sitc Fee And Other Income Earned From Unconsolidated Joint Ventures
FeeAndOtherIncomeEarnedFromUnconsolidatedJointVentures
3100000
CY2023Q1 sitc Gain Loss On Sale Of Interest In Joint Venture
GainLossOnSaleOfInterestInJointVenture
3700000
CY2023Q1 us-gaap Business Combination Pro Forma Information Revenue Of Acquiree Since Acquisition Date Actual
BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual
600000
CY2023Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
83537000
CY2022Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
87748000
CY2023Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
17914000
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
18197000
CY2023Q1 us-gaap Prepaid Expense Current And Noncurrent
PrepaidExpenseCurrentAndNoncurrent
19280000
CY2022Q4 us-gaap Prepaid Expense Current And Noncurrent
PrepaidExpenseCurrentAndNoncurrent
6721000
CY2023Q1 sitc Swap Receivable
SwapReceivable
5400000
CY2022Q4 sitc Swap Receivable
SwapReceivable
8138000
CY2023Q1 us-gaap Derivative Fair Value Of Derivative Net
DerivativeFairValueOfDerivativeNet
5100000
CY2022Q4 us-gaap Derivative Fair Value Of Derivative Net
DerivativeFairValueOfDerivativeNet
8100000
CY2023Q1 us-gaap Senior Notes
SeniorNotes
1454462000
CY2022Q4 us-gaap Senior Notes
SeniorNotes
1453923000
CY2023Q1 sitc Revolving Credit Facility And Term Loan
RevolvingCreditFacilityAndTermLoan
273605000
CY2022Q4 sitc Revolving Credit Facility And Term Loan
RevolvingCreditFacilityAndTermLoan
198521000
CY2023Q1 us-gaap Notes And Loans Payable
NotesAndLoansPayable
54201000
CY2022Q4 us-gaap Notes And Loans Payable
NotesAndLoansPayable
54577000
CY2023Q1 us-gaap Debt Longterm And Shortterm Combined Amount
DebtLongtermAndShorttermCombinedAmount
1782268000
CY2022Q4 us-gaap Debt Longterm And Shortterm Combined Amount
DebtLongtermAndShorttermCombinedAmount
1707021000
CY2023Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.13
CY2022Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.13
CY2023Q1 us-gaap Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
1500000
CY2023Q1 sitc Shares Repurchased Value At Cost
SharesRepurchasedValueAtCost
20000000.0
CY2023Q1 us-gaap Treasury Stock Acquired Average Cost Per Share
TreasuryStockAcquiredAverageCostPerShare
13.43
CY2023Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
-2269000
CY2023Q1 sitc Amounts Reclassified From Accumulated Other Comprehensive Income To Interest Expense
AmountsReclassifiedFromAccumulatedOtherComprehensiveIncomeToInterestExpense
931000
CY2023Q1 us-gaap Profit Loss
ProfitLoss
15302000
CY2022Q1 us-gaap Profit Loss
ProfitLoss
13955000
CY2023Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
18000
CY2022Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
18000
CY2023Q1 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
2789000
CY2022Q1 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
2789000
CY2023Q1 us-gaap Undistributed Earnings Loss Allocated To Participating Securities Basic
UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic
107000
CY2022Q1 us-gaap Undistributed Earnings Loss Allocated To Participating Securities Basic
UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic
126000
CY2023Q1 sitc Net Income Loss Attributable To Common Shareholders After Allocation To Participating Securities
NetIncomeLossAttributableToCommonShareholdersAfterAllocationToParticipatingSecurities
12388000
CY2022Q1 sitc Net Income Loss Attributable To Common Shareholders After Allocation To Participating Securities
NetIncomeLossAttributableToCommonShareholdersAfterAllocationToParticipatingSecurities
11022000
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
209971000
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
212103000
CY2023Q1 sitc Performance Restricted Stock Units
PerformanceRestrictedStockUnits
436000
CY2022Q1 sitc Performance Restricted Stock Units
PerformanceRestrictedStockUnits
1100000
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
210407000
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
213203000
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.06
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.05
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.06
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.05

Files In Submission

Name View Source Status
0000950170-23-015263-index-headers.html Edgar Link pending
0000950170-23-015263-index.html Edgar Link pending
0000950170-23-015263.txt Edgar Link pending
0000950170-23-015263-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
sitc-20230331.htm Edgar Link pending
sitc-20230331.xsd Edgar Link pending
sitc-ex31_1.htm Edgar Link pending
sitc-ex31_2.htm Edgar Link pending
sitc-ex32_1.htm Edgar Link pending
sitc-ex32_2.htm Edgar Link pending
sitc-20230331_def.xml Edgar Link unprocessable
sitc-20230331_lab.xml Edgar Link unprocessable
sitc-20230331_cal.xml Edgar Link unprocessable
sitc-20230331_pre.xml Edgar Link unprocessable
sitc-20230331_htm.xml Edgar Link completed
FilingSummary.xml Edgar Link unprocessable